等级
analytical standard
形式
liquid
组成
Aripiprazole, 100 μg/mL
Lacosamide, 100 μg/mL
Oxcarbazepine, 100 μg/mL
(+)-Propoxyphene, 50 μg/mL
Rufinamide, 100 μg/mL
Warfarin, 1000 μg/mL
包装
ampule of 1 mL
制造商/商品名称
Cerilliant®
drug control
estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
浓度
50-1000 μg/mL each component in acetonitrile
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
应用
forensics and toxicology
格式
multi-component solution
储存温度
−20°C
正在寻找类似产品? 访问 产品对比指南
一般描述
A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.
法律信息
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
WGK
""
闪点(°F)
closed cup
闪点(°C)
closed cup
法规信息
监管及禁止进口产品
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门